Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
2009 1
2010 1
2011 3
2012 3
2013 8
2014 3
2015 5
2016 9
2017 12
2018 7
2019 8
2020 13
2021 15
2022 21
2023 25
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, Ahmad S, Marsh R, Schwartz L, Behr S, Frankel WL, Collisson E, Leenstra J, Williams TM, Vaccaro G, Venook A, Meyerhardt JA, O'Reilly EM. Katz MHG, et al. Among authors: chuong m. JAMA Oncol. 2022 Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319. JAMA Oncol. 2022. PMID: 35834226 Free PMC article. Clinical Trial.
CROSSing into New Therapies for Esophageal Cancer.
Buckstein MH, Anker CJ, Chuong MD, Hawkins MA, Kharofa J, Olsen JR. Buckstein MH, et al. Among authors: chuong md. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):5-10. doi: 10.1016/j.ijrobp.2021.12.177. Int J Radiat Oncol Biol Phys. 2022. PMID: 35427559 No abstract available.
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP. Sperduto PW, et al. Among authors: chuong m. J Clin Oncol. 2020 Nov 10;38(32):3773-3784. doi: 10.1200/JCO.20.01255. Epub 2020 Sep 15. J Clin Oncol. 2020. PMID: 32931399 Free PMC article.
MRI-Guided Adaptive Radiation Therapy.
Benitez CM, Chuong MD, Künzel LA, Thorwarth D. Benitez CM, et al. Among authors: chuong md. Semin Radiat Oncol. 2024 Jan;34(1):84-91. doi: 10.1016/j.semradonc.2023.10.013. Semin Radiat Oncol. 2024. PMID: 38105097 Review.
Advances in MRI-Guided Radiation Therapy.
Chuong MD, Palm RF, Tjong MC, Hyer DE, Kishan AU. Chuong MD, et al. Surg Oncol Clin N Am. 2023 Jul;32(3):599-615. doi: 10.1016/j.soc.2023.02.008. Epub 2023 Apr 4. Surg Oncol Clin N Am. 2023. PMID: 37182995 Review.
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC, Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD. Parikh PJ, et al. Among authors: chuong md. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):799-808. doi: 10.1016/j.ijrobp.2023.05.023. Epub 2023 May 19. Int J Radiat Oncol Biol Phys. 2023. PMID: 37210048 Free article. Clinical Trial.
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.
Proton beam therapy for liver cancers.
Chuong M, Kaiser A, Molitoris J, Mendez Romero A, Apisarnthanarax S. Chuong M, et al. J Gastrointest Oncol. 2020 Feb;11(1):157-165. doi: 10.21037/jgo.2019.04.02. J Gastrointest Oncol. 2020. PMID: 32175119 Free PMC article. Review.
The Evolving Personalized Landscape of Colorectal Cancer Therapies.
Anker CJ, Buckstein MH, Chuong MD, Hawkins MA, Kharofa J, Raldow AC, Tait D, Olsen JR. Anker CJ, et al. Among authors: chuong md. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1255-1262. doi: 10.1016/j.ijrobp.2021.03.016. Int J Radiat Oncol Biol Phys. 2021. PMID: 34273318 No abstract available.
128 results